ASHP therapeutic position statement on the institutional use of 0.9% sodium chloride injection to maintain patency of peripheral indwelling intermittent infusion devices

American Journal of Health-System Pharmacy

Volumn 63, Issue 13, 2006, Pages 1273-1275

  Brand, Alicia ^a   Burkhardt, Mary E ^a   Dager, William E ^a   Hess, Mary M ^a  

^a NONE

Author keywords

American Society of Health System Pharmacists; Anticoagulants; Catheters; Diluents; Drug comparisons; Economics; Guidelines; Heparin; Incompatibilities; Injections; Sodium chloride; Stability; Toxicity

Indexed keywords

HEPARIN; SODIUM CHLORIDE;

ARTICLE; BLEEDING; DRUG EFFICACY; DRUG INCOMPATIBILITY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INDWELLING CATHETER; INFUSION SYSTEM; PRIORITY JOURNAL; RISK ASSESSMENT; TECHNIQUE;

EID: 33745789615     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060094     Document Type: Article

References (43)

1. Millam DA. Intermittent devices. NITA. 1981; 4:142-5.
2. Larkin M. Heparin locks. NITA. 1979; 2:18-9.
3. Thomas RB, Salter FJ. Heparin locks: their advantages and disadvantages. Hosp Formul. 1975; 10:536-8.
4. Deeb EN, Di Mattia PE. How much heparin in the lock? Am J IV Ther. 1976; 3:22-6.
5. Tuten SH, Gueldner SH. Efficacy of sodium chloride versus dilute heparin for maintenance of peripheral intermittent intravenous devices. Appl Nurs Res. 1991; 2:63-71.
6. Hanson RL, Grant AM, Majors KR. Heparin-lock maintenance with ten units of sodium heparin in one milliliter of normal saline solution. Surg Gynecol Obstet. 1976; 142:373-6.
7. Garrelts JC. White clot syndrome and thrombocytopenia: reasons to abandon heparin i.v. lock flush solution. Clin Pharm. 1992; 11:797-9.
8. Weber DR. Is heparin really necessary in the lock and, if so, how much? DICP. 1991; 25:399-407.
9. Barrett PJ, Lester RL. Heparin versus saline flushing solutions in a small community hospital. Hosp Pharm. 1990; 25:115-8.
10. Dunn DL, Lenihan SF. The case for the saline flush. Am J Nurs. 1987; 87:798-9.
11. Goode CJ, Tiller M, Rakel B et al. A metaanalysis of effects of heparin flush and saline flush: quality and cost implications. Nurs Res. 1991; 40:324-30.
12. Fry B. Intermittent heparin flushing protocols. A standardization issue. J Intraven Nurs. 1992; 15:160-3.
13. Epperson EL. Efficacy of 0.9% sodium chloride injection with and without heparin for maintaining indwelling intermittent injection sites. Clin Pharm. 1984; 3:626-9.
14. Garrelts JC, LaRocca J, Ast D et al. Comparison of heparin and 0.9% sodium chloride injection in the maintenance of indwelling intermittent i.v. devices. Clin Pharm. 1989; 8:34-9.
15. Hamilton RA, Plis JM, Clay C et al. Heparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling intermittent infusion devices. Clin Pharm. 1988; 7:439-43.
16. Shearer J. Normal saline versus dilute heparin flush: a study of peripheral intermittent i.v. devices. NITA. 1987; 10:425-7.
17. Miracle V, Fangman B, Kayrouz P et al. Normal saline vs. heparin lock flush solution: one institution's findings. Ky Nurse. 1989; 37(Jul-Aug):1,6-7.
18. Ashton J, Gibson V, Summers S. Effects of heparin versus saline solution on intermittent infusion device irrigation. Heart Lung. 1990; 19:608-12.
19. Hook ML, Ose P. Heparin vs. normal saline. J Intraven Nurs. 1990; 13:150-1. Letter.
20. Cyganski JM, Donahue JM, Heaton JS. The case for the heparin flush. Am J Nurs. 1987; 87:796-7.
21. Holford NH, Vozeh S, Coates P et al. More on heparin lock. N Engl J Med. 1977; 296:1300-1. Letter.
22. Lombardi TP, Gundersen B, Zammett LO et al. Efficacy of 0.9% sodium chloride injection with or without heparin sodium for maintaining patency of intravenous catheters in children. Clin Pharm. 1988; 7:832-6.
23. Shah PS, Ng E, Sinha AK. Heparin for prolonging peripheral intravenous catheter use in neonates. Cochrane Database Syst Rev. 2002; 4:CD002774.
24. Nelson TJ, Graves SM. 0.9% sodium chloride injection with and without heparin for maintaining peripheral indwelling intermittent-infusion devices in infants. Am J Health-Syst Pharm. 1998; 55:570-3.
25. Kleiber C, Hanrahan K, Fagan CL et al. Heparin vs saline for peripheral i.v. locks in children. Pediatr Nurs. 1993; 19:405-9.
26. McMullen A, Fioravanti ID, Pollack V et al. Heparinized saline or normal saline as a flush solution in intermittent intravenous lines in infants and children. MCN Am J Matern Child Nurs. 1993; 18:78-85.
27. Schultz AA, Drew D, Hewitt H. Comparison of normal saline and heparinized saline for patency of IV locks in neonates. App Nurs Res. 2002; 15:28-34.
28. Gyr P, Burroughs T, Smith K et al. Double blind comparison of heparin and saline flush solutions in maintenance of peripheral infusion devices. Pediatr Nurs. 1995:21:383-9.
29. Danek GD, Noris EM. Pediatric i.v. catheters: efficacy of saline flush. Pediatr Nurs. 1992; 18:111-3.
30. Beecroft PC, Bossert E, Chung K et al. Intravenous lock patency in children: dilute heparin versus saline. J Pediatr Pharm Pract. 1997; 2:211-23.
31. Romanowski GL, Zenk KE. Intravenous flush solutions for neonates. Paper presented at ASHP Midyear Clinical Meeting. New Orleans, LA; 1991 Dec 10.
32. Intravenous Nurses Society. Infusion nursing standards. J Intraven Nurs. 2000; 23(6S):S53-4.
33. Lesko SM, Mitchell AA, Epstein MF et al. Heparin use as a risk factor for intraventricular hemorrhage in low-birth-weight infants. N Engl J Med. 1986; 314:1156-60.
34. Malloy MH, Cutter GR. The association of heparin exposure with intraventricular hemorrhage among very low birth weight infants. J Perinatol. 1995; 15:185-91.
35. Meyer BA, Little CJ, Thorp JA et al. Heparin versus normal saline as a peripheral line flush in maintenance of intermittent intravenous lines in obstetric patients. Obstet Gynecol. 1995; 85:433-6.
36. Niesen KM, Harris DY, Parkin LS et al. The effects of heparin versus normal saline for maintenance of peripheral intravenous locks in pregnant women. J Obstet Gynecol Neonatal Nurs. 2003; 32:503-8.
37. Passannante A, Macik BG. The heparin flush syndrome: a cause of iatrogenic hemorrhage. Am J Med Sci. 1988; 296:71-3.
38. Heparin sodium monograph. In: McEvoy GK, ed. AHFS drug information. Bethesda, MD: American Society of Hospital Pharmacists; 2006:2616.
39. Heeger PS, Backstrom JT. Heparin flushes and thrombocytopenia. Ann Intern Med. 1986; 105:143. Letter.
40. Doty JR, Alving BM, McDonnell DE et al. Heparin-associated thrombocytopenia in the neurosurgical patient. Neurosurgery. 1986; 19:69-72.
41. Cines DB, Tomaski A, Tannenbaum S. Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med. 1987; 316:581-9.
42. Trissel LA. Handbook on injectable drugs. 13th ed. Bethesda, MD: American Society of Hospital Pharmacists; 2005.
43. Intravenous Nurses Society. Intravenous nursing. Standards of practice. J Intraven Nurs. 1998; 21(1 suppl):S1-91.